Review article · 2018 · Open access

Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome

Maja Đanić, Bojan Stanimirov, Nebojša Pavlović, Svetlana Goločorbin-Kon, Hani Al‐Salami, Karmen Stankov, Momir Mikov

Frontiers in Pharmacology, 9, 1382 · Published 3 December 2018 · DOI 10.3389/fphar.2018.01382

Open PDFView at the publisherCite this paper

In brief

“Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome” is a 2018 review article by Maja Đanić and 6 co-authors, published in Frontiers in Pharmacology. OpenAlex counts 148 citations as of 21 November 2026. It is open access under a CC BY licence: the full text is free to read at Frontiers in Pharmacology.

Citations
148
Most cited in
2021 (39)
Field-weighted impact
1.85
References
186
Authors
7

Abstract

Apart from well-known functions of bile acids in digestion and solubilization of lipophilic nutrients and drugs in the small intestine, the emerging evidence from the past two decades identified the role of bile acids as signaling, endocrine molecules that regulate the glucose, lipid, and energy metabolism through complex and intertwined pathways that are largely mediated by activation of nuclear receptor farnesoid X receptor (FXR) and cell surface G protein-coupled receptor 1, TGR5 (also known as GPBAR1). Interactions of bile acids with the gut microbiota that result in the altered composition of circulating and intestinal bile acids pool, gut microbiota composition and modified signaling pathways, are further extending the complexity of biological functions of these steroid derivatives. Thus, bile acids signaling pathways have become attractive targets for the treatment of various metabolic diseases and metabolic syndrome opening the new potential avenue in their treatment. In addition, there is a significant effort to unveil some specific properties of bile acids relevant to their intrinsic potency and selectivity for particular receptors and to design novel modulators of these receptors with improved pharmacokinetic and pharmacodynamic profiles. This resulted in synthesis of few semi-synthetic bile acids derivatives such as 6α-ethyl-chenodeoxycholic acid (obeticholic acid, OCA), norursodeoxycholic acid (norUDCA), and 12-monoketocholic acid (12-MKC) that are proven to have positive effect in metabolic and hepato-biliary disorders. This review presents an overview of the current knowledge related to bile acids implications in glucose, lipid and energy metabolism, as well as a potential application of bile acids in metabolic syndrome treatment with future perspectives.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Đanić, M., Stanimirov, B., Pavlović, N., Goločorbin-Kon, S., Al‐Salami, H., Stankov, K., & Mikov, M. (2018). Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome. Frontiers in Pharmacology, 9, 1382. https://doi.org/10.3389/fphar.2018.01382

MLA 9

Đanić, Maja, et al. “Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome.” Frontiers in Pharmacology, vol. 9, 2018, p. 1382. https://doi.org/10.3389/fphar.2018.01382.

Chicago

Đanić, Maja, Bojan Stanimirov, Nebojša Pavlović, Svetlana Goločorbin-Kon, Hani Al‐Salami, Karmen Stankov, and Momir Mikov. 2018. “Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome.” Frontiers in Pharmacology 9: 1382. https://doi.org/10.3389/fphar.2018.01382.

Harvard

Đanić, M. et al. (2018) ‘Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome’, Frontiers in Pharmacology, 9, p. 1382. doi:10.3389/fphar.2018.01382.

IEEE

M. Đanić et al., “Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome,” Frontiers in Pharmacology, vol. 9, p. 1382, 2018, doi: 10.3389/fphar.2018.01382.

BibTeX

@article{anic2018pharmacological,
  title     = {{Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome}},
  author    = {Đanić, Maja and Stanimirov, Bojan and Pavlović, Nebojša and Goločorbin-Kon, Svetlana and Al‐Salami, Hani and Stankov, Karmen and Mikov, Momir},
  journal   = {Frontiers in Pharmacology},
  year      = {2018},
  volume    = {9},
  pages     = {1382},
  doi       = {10.3389/fphar.2018.01382},
  url       = {https://doi.org/10.3389/fphar.2018.01382}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201711
20191010
20201717
20213939
20221717
20231313
20241919
20251818
20261414

Its field-weighted citation impact is 1.85: it has been cited 1.85 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms

  • bile acids
  • bile acid derivatives
  • metabolic syndrome
  • farnesoid X receptor
  • TGR5
  • gut microbiota
  • bile acid signaling
  • glucose metabolism

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Đanić, M., Stanimirov, B., Pavlović, N., Goločorbin-Kon, S., Al‐Salami, H., Stankov, K., & Mikov, M. (2018). Pharmacological Applications of Bile Acids and Their Derivatives in the Treatment of Metabolic Syndrome. Frontiers in Pharmacology, 9, 1382. https://doi.org/10.3389/fphar.2018.01382

How many times has this paper been cited?

148 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Frontiers in Pharmacology: sign in and open the PDF from this page.

Who wrote this paper?

Maja Đanić, Bojan Stanimirov, Nebojša Pavlović, Svetlana Goločorbin-Kon, Hani Al‐Salami, Karmen Stankov, Momir Mikov.

What is the DOI of this paper?

10.3389/fphar.2018.01382, permanently at https://doi.org/10.3389/fphar.2018.01382. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.